CLDN8 and familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis: While we have identified promising potential modifier variants in NFU1, DMD, HPS5, CLDN8 and CLDN17, their functional impact on FHHNC progression towards kidney failure remains to be characterized.